Blue Earth Therapeutics Ltd clinical trials

A subsidiary of Bracco

The registry lists 2 studies whose lead sponsor is Blue Earth Therapeutics Ltd. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 14, 2026.

Status

Terminated: 1
Recruiting: 1

Phase

Early Phase 1: 1
Phase 1: 1
Phase 2: 1

Where

United States: 2
Netherlands: 2
Spain: 1
Germany: 1
Belgium: 1
United Kingdom: 1

Registry sponsor names on this page

Blue Earth Therapeutics Ltd2 studies

Something wrong with this grouping? Tell us on the Bracco page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Bracco studies →

Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionRecruitingNCT05413850Phase 1/2
Sponsor listed in the registry: Blue Earth Therapeutics Ltd
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate CancerTerminatedNCT06516510Early Phase 1
Sponsor listed in the registry: Blue Earth Therapeutics Ltd